Trial intelligence / Profile preview

Interdialytic Serum Bicarbonate Correction on Vascular Calcification in Hemodialysis Patients

NCT07765459Phase 1Completed

Sponsor
Ain Shams University
Start
Sep 2023
Primary completion
Feb 2024
Countries
1
01

Overview

Phase 1, randomised, open-label trial of sodium bicarbonate in metabolic acidosis (2 arms), sponsored by Ain Shams University. Primary endpoint: Correction of acidosis and its effect on vascular calcification at 6 months. Started Sep 2023; status: completed.

02

Drugs

sodium bicarbonate
03

Conditions

metabolic acidosis

Beyond the preview

Go deeper on NCT07765459.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07765459.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call